|
Volumn 21, Issue 4, 2002, Pages 440-445
|
HMG-CoA reductase inhibitor cerivastatin prolonged rat cardiac allograft survival by blocking intercellular signals
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CERIVASTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
INTERCELLULAR ADHESION MOLECULE 1;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
ATHEROSCLEROSIS;
CONTROLLED STUDY;
DILUTION;
DRUG EFFECT;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HYPERLIPIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
MALE;
MONONUCLEAR CELL;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ANIMALS;
DISEASE MODELS, ANIMAL;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
IMMUNE TOLERANCE;
IMMUNOHISTOCHEMISTRY;
INTERCELLULAR ADHESION MOLECULE-1;
INTERLEUKIN-2;
LEUKOCYTES;
LYMPHOCYTE CULTURE TEST, MIXED;
LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1;
MALE;
MODELS, CARDIOVASCULAR;
PYRIDINES;
RATS;
RATS, INBRED F344;
RATS, INBRED LEW;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
|
EID: 0036126837
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: 10.1016/S1053-2498(01)00403-X Document Type: Article |
Times cited : (16)
|
References (21)
|